SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-368368
Filing Date
2015-11-05
Accepted
2015-11-05 16:30:27
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d94915d10q.htm 10-Q 436251
2 EX-10.1 d94915dex101.htm EX-10.1 409122
3 EX-10.2 d94915dex102.htm EX-10.2 100741
4 EX-31.1 d94915dex311.htm EX-31.1 6885
5 EX-32.1 d94915dex321.htm EX-32.1 4446
12 GRAPHIC g94915image001.jpg GRAPHIC 23559
  Complete submission text file 0001193125-15-368368.txt   2396140

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acad-20150930.xml EX-101.INS 246987
7 XBRL TAXONOMY EXTENSION SCHEMA acad-20150930.xsd EX-101.SCH 22750
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20150930_cal.xml EX-101.CAL 41904
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20150930_def.xml EX-101.DEF 58241
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20150930_lab.xml EX-101.LAB 181253
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20150930_pre.xml EX-101.PRE 124146
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 151201086
SIC: 2834 Pharmaceutical Preparations